US 6436980
Peptidomimetic efflux pump inhibitors
expired A61KA61K38/00
Quick answer
US patent 6436980 (Peptidomimetic efflux pump inhibitors) held by Essential Therapeutics, Inc. expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Essential Therapeutics, Inc.
- Grant date
- Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00